Price T Rowe Associates Inc Guardant Health, Inc. Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Guardant Health, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 842,508 shares of GH stock, worth $25.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
842,508
Previous 1,375,674 38.76%
Holding current value
$25.7 Million
Previous $39.7 Million 51.35%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$22.3 - $36.29 $11.9 Million - $19.3 Million
-533,166 Reduced 38.76%
842,508 $19.3 Million
Q2 2024

Aug 14, 2024
SELL
$16.07 - $31.84 $2.72 Million - $5.39 Million
-169,440 Reduced 10.97%
1,375,674 $39.7 Million
Q1 2024

May 15, 2024
SELL
$17.13 - $26.91 $4.7 Million - $7.39 Million
-274,470 Reduced 15.08%
1,545,114 $31.9 Million
Q4 2023

Feb 14, 2024
SELL
$21.58 - $29.5 $20 Million - $27.3 Million
-926,378 Reduced 33.74%
1,819,584 $49.2 Million
Q3 2023

Nov 14, 2023
SELL
$25.8 - $39.97 $37.9 Million - $58.7 Million
-1,469,418 Reduced 34.86%
2,745,962 $81.4 Million
Q2 2023

Aug 14, 2023
BUY
$20.94 - $38.01 $53 Million - $96.3 Million
2,532,687 Added 150.51%
4,215,380 $151 Million
Q1 2023

May 15, 2023
SELL
$22.92 - $33.76 $464,978 - $684,889
-20,287 Reduced 1.19%
1,682,693 $39.4 Million
Q4 2022

Feb 14, 2023
BUY
$25.44 - $59.78 $2.76 Million - $6.48 Million
108,381 Added 6.8%
1,702,980 $46.3 Million
Q3 2022

Nov 14, 2022
BUY
$43.66 - $61.0 $1.04 Million - $1.46 Million
23,857 Added 1.52%
1,594,599 $85.8 Million
Q2 2022

Aug 15, 2022
BUY
$28.82 - $77.35 $6.56 Million - $17.6 Million
227,675 Added 16.95%
1,570,742 $63.4 Million
Q1 2022

May 16, 2022
BUY
$48.25 - $100.49 $1.6 Million - $3.33 Million
33,150 Added 2.53%
1,343,067 $89 Million
Q4 2021

Feb 14, 2022
SELL
$88.71 - $120.43 $164 Million - $222 Million
-1,847,006 Reduced 58.51%
1,309,917 $131 Million
Q3 2021

Nov 15, 2021
BUY
$98.77 - $132.17 $156 Million - $209 Million
1,577,628 Added 99.89%
3,156,923 $395 Million
Q2 2021

Aug 16, 2021
BUY
$109.77 - $165.68 $4.22 Million - $6.36 Million
38,411 Added 2.49%
1,579,295 $196 Million
Q1 2021

May 17, 2021
BUY
$127.04 - $179.1 $13.8 Million - $19.4 Million
108,510 Added 7.58%
1,540,884 $235 Million
Q4 2020

Feb 16, 2021
BUY
$99.96 - $135.93 $143 Million - $195 Million
1,432,374 New
1,432,374 $185 Million

Others Institutions Holding GH

# of Institutions
323
Shares Held
127M
Call Options Held
844K
Put Options Held
2.38M
View Full List

About Guardant Health, Inc.

GH Quotes by TradingView
  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.12B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email